معرفی
Dr. Hui Xin Ong is a Senior Research Fellow at the Macquarie Medical School, specializing in respiratory drug delivery systems and aerosol particle interactions. She also serves as Research Leader at the Woolcock Institute of Medical Research (since 2020) and Director at Ab Initio Pharma (since 2019).
- PhD in Pharmaceutical Science (University of Sydney, 2013)
- Bachelor of Pharmacy (Hons) (University of Sydney, 2009)
Her research bridges basic, applied, and clinical disciplines, focusing on:
- Respiratory disease treatment technologies
- Aerosol-lung biological barrier interactions
- Smart nanogel formulations for Alzheimer's
- Targeted nasal-brain drug delivery
Recent publications highlight 3D-printed drug devices, mRNA-lipid nanoparticle delivery, and circadian rhythm modulation in neurodegenerative diseases. Collaborations span academia (Monash University) and industry partners.
- Scientific Awards:
- Award for Excellence in Postgraduate Education (2019)
- DDL Emerging Scientist Award (2021)
- Best Early Career Research Award (2014)
- Award for Reduction in Animal Use (2015)
۰مقاله منتشرشده
